Natural History Study for Charcot Marie Tooth Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-11-01

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this Natural History Study for Charcot-Marie-Tooth is to acquire, record, and analyze patient-reported data and associated genetic reports, Electronic Health Records (EHRs) and clinical notes to identify the burden, diagnostic journey, and prevalence of disease that will aid scientists in their work toward finding a cure.

Participants will be asked to complete a Natural History Survey.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Natural History of the Progression of Choroideremia Study

NCT03359551

Choroideremia

COMPLETED

Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers

NCT01604122

Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) Transthyretin Cardiomyopathy (TTR-CM) Familial Amyloid Cardiomyopathy +1 more

COMPLETED

Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

NCT07257289

Hereditary Heart Diseases

NOT_YET_RECRUITING

The Study of the Prevalence Fibromuscular Dysplasia in Patient With Haematoma or Spontaneous Coronary Artery Dissection.

NCT02799186

Spontaneous Coronary Artery Dissection Spontaneous Coronary Artery Haematoma

COMPLETED NA

Genetic Factors in Atherosclerosis

NCT00359307

Atherosclerosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Charcot-Marie-Tooth Disease Charcot-Marie-Tooth Charcot-Marie-Tooth Disease, Type IA Charcot-Marie-Tooth Disease Type 2A Charcot-Marie-Tooth Disease Type 2 Charcot-Marie-Tooth Disease, Type 2C Charcot-Marie-Tooth Disease Type 2A2B Charcot-Marie-Tooth Disease Type 2B2 Charcot-Marie-Tooth Disease Type 2A1 Charcot-Marie-Tooth Disease Type 4B1 Charcot-Marie-Tooth Disease, Type IB Charcot-Marie-Tooth Disease Type 2B1 Charcot-Marie-Tooth Disease Type 2U (Diagnosis) Charcot-Marie-Tooth Disease Type 4A Charcot-Marie-Tooth Disease, Type 4A, Axonal Form Charcot-Marie-Tooth Disease Type 2A2A Charcot-Marie-Tooth Disease Type 2S (Disorder) Charcot-Marie-Tooth Disease and Deafness Charcot-Marie-Tooth Disease Type 4B2 Charcot-Marie-Tooth Disease Type 4H Charcot-Marie-Tooth Disease Type 1F Charcot-Marie-Tooth Disease Type 4C Charcot-Marie-Tooth Disease Type 4E Charcot-Marie-Tooth Disease Type 1D Charcot-Marie-Tooth Disease Type 2Q (Diagnosis) Charcot-Marie-Tooth Disease Type 2A2 Charcot-Marie-Tooth Disease Type 2N (Diagnosis) Charcot-Marie-Tooth Disease Type 2B5 Charcot-Marie-Tooth Disease Type 2D Charcot-Marie-Tooth Disease Type 4D Charcot-Marie-Tooth Disease Type 2K Charcot-Marie-Tooth Disease Type 2L (Diagnosis) Charcot-Marie-Tooth Disease Type 2T Charcot-Marie-Tooth Disease Type 2I Charcot-Marie-Tooth Disease Type 2J Charcot-Marie-Tooth Disease Type 2E Charcot-Marie-Tooth Disease Type 2G Charcot-Marie-Tooth Disease Type 1C Charcot-Marie-Tooth Disease Type 2R Charcot-Marie-Tooth Disease Type 2O (Diagnosis) Charcot-Marie-Tooth Disease Type 2M Charcot-Marie-Tooth Disease Type 2P Charcot-Marie-Tooth Disease Type 2Y Charcot-Marie-Tooth Disease Type 4F (Diagnosis) Charcot-Marie-Tooth Disease Type 4B3 Charcot-Marie-Tooth Disease Type 2H HNPP X-Linked Charcot-Marie-Tooth Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients will be made aware of the study by HNF and others (referenced above) and invited to participate. Once patients have reviewed and signed electronically the informed consent document, it is attached to their file.

All affected individuals with CMT/IN are eligible to participate in GRIN with proper informed consent.

Children, adolescents and adults with either a confirmed diagnosis or suspected to have CMT/IN are eligible with parent and/or guardian consent.

Individuals that have been clinically diagnosed through family history and/or standard clinical testing (e.g. neuro exam, EMG, NCS) and/or genetically tested or suspected to have CMT/IN (note: many mutations have not been identified yet) are eligible.